CHANGES IN PITUITARY-ADRENAL ACTIVITY AFFECT THE BINDING-PROPERTIES OF STRIATAL DOPAMINE D-2 RECEPTORS BUT NOT THEIR MODULATION BY NEUROTENSIN AND CHOLECYSTOKININ-8

被引:14
作者
VONEULER, G [1 ]
FUXE, K [1 ]
TANGANELLI, S [1 ]
FINNMAN, UB [1 ]
ENEROTH, P [1 ]
机构
[1] HUDDINGE HOSP, APPL BIOCHEM UNIT, S-14186 HUDDINGE, SWEDEN
关键词
D O I
10.1016/0197-0186(90)90102-Y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effects of adrenalectomy were investigated on the binding properties of [3H]N-propylnorapomorphine ([3H]NPA) binding sites in membrane preparations from the rat neostriatum. Adrenalectomy (1 week) was found to increase the KD value of [3H]NPA binding sites by 30 ± 3%, without affecting the Bmax values. These effects were fully counteracted by replacement treatment with corticosterone (5 mg/kg, twice daily, 1 week, last injection given 2 h before killing). The ability of neurotensin and cholecystokinin-8 (sulphated) in vitro to increase the KD value of [3H]NPA binding sites was maintained also following adrenalectomy. The average increases were 16±7 and 21±6%, respectively. When added together the two peptides failed to increase the KD value any further. The Bmax values of [3H]NPA binding sites were not affected by either adrenalectomy or by the peptides. These results indicate a glucocorticoid regulation of the binding characteristics of dopamine D-2 receptors in the rat striatum. The mechanism mediating the effects of adrenalectomy may involve an altered expression or regulation of the D-2 receptor or of its connected G-proteins. Probably, it is different from the mechanism whereby the neuropeptides modulate the D-2 receptor, since the neuropeptide-induced modulation was also maintained following the changes induced by adrenalectomy. © 1990.
引用
收藏
页码:275 / 280
页数:6
相关论文
共 30 条
[1]   SUBCORTICAL LIMBIC H-3 N-PROPYLNORAPOMORPHINE BINDING-SITES ARE MARKEDLY MODULATED BY CHOLECYSTOKININ-8 INVITRO [J].
AGNATI, LF ;
FUXE, K .
BIOSCIENCE REPORTS, 1983, 3 (12) :1101-1105
[2]   NEUROTENSIN INVITRO MARKEDLY REDUCES THE AFFINITY IN SUBCORTICAL LIMBIC N-PROPYLNORAPOMORPHINE-H-3 BINDING-SITES [J].
AGNATI, LF ;
FUXE, K ;
BENFENATI, F ;
BATTISTINI, N .
ACTA PHYSIOLOGICA SCANDINAVICA, 1983, 119 (04) :459-461
[3]   CHOLECYSTOKININ PEPTIDES INVITRO MODULATE THE CHARACTERISTICS OF THE STRIATAL H-3 N-PROPYLNORAPOMORPHINE SITES [J].
AGNATI, LF ;
CELANI, MF ;
FUXE, K .
ACTA PHYSIOLOGICA SCANDINAVICA, 1983, 118 (01) :79-81
[4]   EVIDENCE FOR CHOLECYSTOKININ-DOPAMINE RECEPTOR INTERACTIONS IN THE CENTRAL NERVOUS-SYSTEM OF THE ADULT AND OLD RAT - STUDIES ON THEIR FUNCTIONAL MEANING [J].
AGNATI, LF ;
FUXE, K ;
GIARDINO, L ;
CALZA, L ;
ZOLI, M ;
BATTISTINI, N ;
BENFENATI, F ;
VANDERHAEGHEN, JJ ;
GUIDOLIN, D ;
RUGGERI, M ;
GOLDSTEIN, M .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1985, 448 (JUL) :315-333
[5]   DOPAMINE RECEPTOR-BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTI-SCHIZOPHRENIC DRUGS [J].
CREESE, I ;
BURT, DR ;
SNYDER, SH .
SCIENCE, 1976, 192 (4238) :481-483
[6]   N-N-PROPYLNORAPOMORPHINE-H-3 - NOVEL AGONIST LIGAND FOR CENTRAL DOPAMINE RECEPTORS [J].
CREESE, I ;
PADGETT, L ;
FAZZINI, E ;
LOPEZ, F .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1979, 56 (04) :411-412
[7]   ADRENOCORTICAL HORMONE STATUS AFFECTS RESPONSES TO DOPAMINE RECEPTOR AGONISTS [J].
FAUNT, JE ;
CROCKER, AD .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 152 (03) :255-261
[8]   EFFECTS OF ADRENALECTOMY ON RESPONSES MEDIATED BY DOPAMINE D-1 AND D-2 RECEPTORS [J].
FAUNT, JE ;
CROCKER, AD .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 162 (02) :237-244
[9]  
FUXE K, 1984, NEUROCHEM INT, V6, P737, DOI 10.1016/0197-0186(84)90005-6
[10]   MAPPING OF GLUCOCORTICOID RECEPTOR IMMUNOREACTIVE NEURONS IN THE RAT TELENCEPHALON AND DIENCEPHALON USING A MONOCLONAL-ANTIBODY AGAINST RAT-LIVER GLUCOCORTICOID RECEPTOR [J].
FUXE, K ;
WIKSTROM, AC ;
OKRET, S ;
AGNATI, LF ;
HARFSTRAND, A ;
YU, ZY ;
GRANHOLM, L ;
ZOLI, M ;
VALE, W ;
GUSTAFSSON, JA .
ENDOCRINOLOGY, 1985, 117 (05) :1803-1812